Search Results

1 - 2 of 2 items :

  • Haematology, Oncology x
Clear All
Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control

) 6.0 ± 0.7 Child-Pugh score (classes), n [%]:  A 22 [73.3]  B 8 [26.7] Creatinine [μmol/l] 81.7 ± 23.4 ASAT [μkat/l] 1. 1 ± 0.7 ALAT [μkat/l] 0.8 ± 0.6 γGT [μkat/l] 2.3 ± 1.6 αFP [kIE/l] 152.5 ± 310.2 Portal vein thrombosis (yes/no), n [%] 6/29 [17.1/82.9] Bilobar disease, n [%] 11 [31.4] Unilobar disease, n [%:] 24 [68.6] right lobe, n [%] 20 [83.3] Overall number of nodules, n 97 Number of nodules per pt, n 2.8 ± 2.2 Maximum diameter of HCC nodule

Open access
Computed tomographic perfusion imaging for the prediction of response and survival to transarterial chemoembolization of hepatocellular carcinoma

Age [years] 68.8 ± 5.8 Sex (M/F), n [%] 17/1 [94.4/5.6] Cirrhosis (yes/no), n [%] 16/2 [88.9/11.1] Aetiology of cirrhosis, n [%] Alcohol 7 [43.8] HBV 3 [18.8] HCV 1 [6.3] Other 5 [31.3] Albumin [g/l] 38.3 ± 5.1 INR 1.2 ± 0.3 Total bilirubin [mmol/l] 23.6 ± 18.8 Child-Pugh score (points) 5.7 ± 0.8 A, n [%] 14 [77.8] B, n [%] 4 [22.2] Creatinine [µmol/l] 87.8 ± 22.8 AST [µkat/l] 1.1 ± 0.9 ALT [µkat/l] 0.9 ± 0.8 γGT [µkat/l] 1

Open access